Cargando…
The feasibility of polypill for cardiovascular disease prevention in Asian Population
Polypill is a fixed‐dose combination of medications with proven benefits for the prevention of cardiovascular disease (CVD). Its role in CVD prevention has been extensively debated since the inception of this concept in 2003. There are two major kinds of polypills in clinical studies. The first is p...
Autores principales: | Sukonthasarn, Apichard, Chia, Yook‐Chin, Wang, Ji‐Guang, Nailes, Jennifer, Buranakitjaroen, Peera, Van Minh, Huynh, Verma, Narsingh, Hoshide, Satoshi, Shin, Jinho, Turana, Yuda, Tay, Jam Chin, Teo, Boon Wee, Siddique, Saulat, Sison, Jorge, Zhang, Yu‐Qing, Wang, Tzung‐Dau, Chen, Chen‐Huan, Kario, Kazuomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029502/ https://www.ncbi.nlm.nih.gov/pubmed/33086429 http://dx.doi.org/10.1111/jch.14075 |
Ejemplares similares
-
Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
por: Lin, Donna S.‐H., et al.
Publicado: (2020) -
Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2020) -
Disaster hypertension and cardiovascular events in disaster and COVID‐19 pandemic
por: Narita, Keisuke, et al.
Publicado: (2021) -
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020) -
Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE‐Asia Network
por: Chia, Yook‐Chin, et al.
Publicado: (2021)